Von Willebrand disease and quantitative variation in von Willebrand factor

Journal of Laboratory and Clinical Medicine

Volumn 130, Issue 3, 1997, Pages 252-261

  Mohlke, Karen L ^a   Ginsburg, David ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b 4520 MSRB I ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031239285     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90019-6     Document Type: Review

References (110)

1. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987;69:454-9.
2. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993;123:893-8.
3. Ginsburg D, Bowie EJW. Molecular genetics of von Willebrand disease. Blood 1992;79:2507-19.
4. Blann AD, Porter M, McCollum CN. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1992;68:635.
5. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332:635-41.
6. Penny WF, Weinstein M, Salzman EW, Ware JA. Correlation of circulating von Willebrand factor levels with cardiovascular hemodynamics. Circulation 1991;83:1630-6.
7. Talbot S, Wakley EJ, Ryrie D, Langman MJ. ABO blood-groups and venous thromboembolic disease. Lancet 1970;1: 1257-9.
8. Kingsbury KJ. Relation of ABO blood-groups to atherosclerosis. Lancet 1971;1:199-203.
9. Bonthron DT, Orr EC, Mitsock LM, Ginsburg D, Handin RI, Orkin SH. Nucleotide sequence of pre-pro-von Willebrand factor cDNA. Nucleic Acids Res 1986;14:7125-7.
10. Mancuso DJ, Tuley EA, Westfield LA, et al. Structure of the gene for human von Willebrand factor. J Biol Chem 1989;264:19514-27.
11. Ginsburg D, Handin RI, Bonthron DT, et al. Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Science 1985;228:1401-6.
12. Shelton-Inloes BB, Titani K, Sadler JE. cDNA sequences for human von Willebrand factor reveal five types of repeated domains and five possible protein sequence polymorphisms. Biochemistry 1986;25:3164-71.
13. Sadler JE. von Willebrand factor. J Biol Chem 1991;266: 22777-80.
14. Ruggeri ZM, Ware J, Ginsburg D. von Willebrand factor. In: Loscalzo J, Schafer AI, editors. Thrombosis and hemorrhage. Boston: Blackwell Scientific Publishers Inc., 1994: 305-29.
15. Jaffe EA, Hoyer LW, Nachman RL. Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest 1973;52:2757-64.
16. Sporn LA, Chavin SI, Marder VJ, Wagner DD. Biosynthesis of von Willebrand protein by human megakaryocytes. J Clin Invest 1985;76:1102-6.
17. Harrison RL, McKee PA. Estrogen stimulates von Willebrand factor production by cultured endothelial cells. Blood 1984;63:657-65.
18. Alperin JB. Estrogens and surgery in women with von Willebrand's disease. Am J Med 1982;73:367-71.
19. Triplett DA. Laboratory diagnosis of von Willebrand's disease. Mayo Clin Proc 1991;66:832-40.
20. Dalton RG, Dewar MS, Savidge GF, et al. Hypothyroidism as a cause of acquired von Willebrand's disease. Lancet 1987;1:1007-9.
21. Rogers JS, Shane SR, Jencks FS. Factor VIII activity and thyroid function. Ann Intern Med 1982;97:713-6.
22. Sporn LA, Marder VJ, Wagner DD. Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell 1986;46:185-90.
23. Savage B, SaldRvar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996;84:289-97.
24. Pareti FI, Niiya K, McPherson JM, Ruggeri ZM. Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III. J Biol Chem 1987;262:13835-41.
25. Rand JH, Patel ND, Schwartz E, Zhou S-L, Potter BJ. 150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen. J Clin Invest 1991;88:253-9.
26. 728. J Biol Chem 1987;262:1734-9.
27. Fretto LJ, Fowler WE, McCaslin DR, Erickson HP, McKee PA. Substructure of human von Willebrand factor: proteolysis by V8 and characterization of two functional domains. J Biol Chem 1986;261:15679-89.
28. Roberts DD, Williams SB, Gralnick HR, Ginsburg V. von Willebrand factor binds specifically to sulfated glycolipids. J Biol Chem 1986;261:3306-9.
29. Sakariassen KS, Bolhuis PA, Sixma JJ. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium. Nature 1979;279:636-8.
30. Ruggeri ZM. Glycoprotein Ib and von Willebrand factor in the process of thrombus formation. Ann N Y Acad Sci 1994;714:200-10.
31. Cooper HA, Griggs TR, Wagner RH. Factor VIII recombination after dissociation by CaCl12. Proc Natl Acad Sci USA 1973;70:2326-9.
32. Koedam JA, Meijers JC, Sixma JJ, Bouma BN. Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest 1988;82:1236-43.
33. von Willebrand EA. Hereditär pseudohemofili. Finska Läkarsällskapetes Handl 1926;67:7-112.
34. Zhang ZP, Blombäck M, Nyman D, Anvret M. Mutations of von Willebrand factor gene in families with von Willebrand disease in the Cland Islands. Proc Natl Acad Sci USA 1993;90:7937-40.
35. Mohlke KL, Nichols WC, Rehemtulla A, et al. A common frameshift mutation in von Willebrand factor does not alter mRNA stability but interferes with normal propeptide processing. Br J Haematol 1996;95:184-91.
36. Bloom AL. von Willebrand factor: clinical features of inherited and acquired disorders. Mayo Clin Proc 1991;66: 743-51.
37. Holmberg L, Nilsson IM. von Willebrand disease. Clin Haematol 1985;14:461-88.
38. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994;71:520-5.
39. Lyons SE, Bruck ME, Bowie EJW, Ginsburg D. Impaired intracellular transport produced by a subset of type ILA von Willebrand disease mutations. J Biol Chem 1992;267:4424-30.
40. Cooney KA, Nichols WC, Bruck ME, et al. The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain. J Clin Invest 1991;87:1227-33.
41. Howard MA, Salem HH, Thomas KB, et al. Variant von Willebrand's disease type B - revisited. Blood 1982;60: 1420-8.
42. Ciavarella G, Ciavarella N, Antoncecchi S, et al. High-resolution analysis of von Willebrand factor multimeric composition defines a new variant of type I von Willebrand disease with aberrant structure but presence of all size multimers (type IC). Blood 1985;66:1423-9.
43. Lopez-Fernandez MF, Gonzalez-Boullosa R, Blanco-Lopez MJ, Perez M, Batlle J. Abnormal proteolytic degradation of von Willebrand factor after desmopressin infusion in a new subtype of von Willebrand disease (ID). Am J Hematol 1991;36:163-70.
44. Rabinowitz I, Tuley EA, Mancuso DJ, et al. von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib. Proc Natl Acad Sci USA 1992;89:9846-9.
45. Cacheris PM, Nichols WC, Ginsburg D. Molecular characterization of a unique von Willebrand disease variant. A novel mutation affecting von Willebrand factor/factor VIII interaction. J Biol Chem 1991;266:13499-502.
46. Nishino M, Girma J-P, Rothschild C, Fressinaud E, Meyer D. New variant of von Willebrand disease with defective binding to factor VIII. Blood 1989;74:1591-9.
47. Mazurier C, Diéval J, Jorieux S, Delobel J, Goudemand M. A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction. Blood 1990;75:20-6.
48. Tuley EA, Gaucher C, Jorieux S, Worrall NK, Sadler JE, Mazurier C. Expression of von Willebrand factor "Normandy": an autosomal mutation that mimics hemophilia A. Proc Natl Acad Sci USA 1991;88:6377-81.
49. Weiss HJ, Ball AP, Mannucci PM. Incidence of severe von Willebrand's disease. N Engl J Med 1982;307:127.
50. Shelton-Inloes BB, Chehab FF, Mannucci PM, Federici AB, Sadler JE. Gene deletions correlate with the development of alloantibodies in von Willebrand disease. J Clin Invest 1987;79:1459-65.
51. Ngo KY, Glotz VT, Koziol JA, et al. Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand Disease. Proc Natl Acad Sci USA 1988;85:2753-7.
52. Peake IR, Liddell MB, Moodie P, et al. Severe type III von Willebrand's disease caused by deletion of Exon 42 of the von Willebrand factor gene: family studies that identify carriers of the condition and a compound heterozygous individual. Blood 1990;75:654-61.
53. Bahnak BR, Lavergne J-M, Rothschild C, Meyer D. A stop codon in a patient with severe, type III, von Willebrand disease. Blood 1991;78:1148-9.
54. Zhang ZP, Falk G, Blombäck M, Egberg N, Anvret M. Identification of a new nonsense mutation in the von Willebrand factor gene in patients with von Willebrand disease type III. Hum Mol Genet 1992;1:61-2.
55. Eikenboom JCJ, Ploos van Amstel HK, Reitsma PH, Briët E. Mutations in severe, type III von Willebrand's disease in the Dutch population: candidate missense and nonsense mutations associated with reduced levels of von Willebrand factor messenger RNA. Thromb Haemost 1992;68:448-54.
56. Zhang ZP, Lindstedt M, Falk G, Blombäck M, Egberg N, Anvret M. Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I. Am J Hum Genet 1992;51:850-8.
57. Nichols WC, Lyons SE, Harrison JS, Cody RL, Ginsburg D. Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis. Proc Natl Acad Sci USA 1991;88:3857-61.
58. Weiss HJ, Piétu G, Rabinowitz R, Girma J-P, Rogers J, Meyer D. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease. J Lab Clin Med 1983;101:411-25.
59. Mannucci PM, Lombardi R, Bader R, et al. Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor. Blood 1985;66: 796-802.
60. Zhang ZP, Lindstedt M, Blombäck M, Anvret M. Effects of the mutant von Willebrand factor gene in von Willebrand disease. Hum Genet 1995;96:388-94.
61. Federici AB, de Groot PG, Moia M, Ijsseldijk MJW, Sixma JJ, Mannucci PM. Type I von Willebrand disease, subtype "platelet low": decreased platelet adhesion can be explained by low synthesis of von Willebrand factor in endothelial cells. Br J Haematol 1993;83:88-93.
62. Eikenboom JCJ, Matsushita T, Reitsma PH, et al. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor. Blood 1996;88:2433-41.
63. Lavergne JM, Piao Y, Ribba AS, et al. Functional analysis of the Arg 91Gln substitution in the factor VIII binding domain of von Willebrand factor demonstrates variable phenotypic expression. Thromb Haemost 1993;70:691-6.
64. 854 by Gln in the putative factor-VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF allele. Br J Haematol 1992; 80:358-63.
65. Siguret V, Lavergne J-M, Chérel G, et al. A novel case of compound heterozygosity with "Normandy"/type I von Willebrand disease (vWD). Direct demonstration of the segregation of one allele with a defective expression at the mRNA level causing type I vWD. Hum Genet 1994;93:95-102.
66. Eikenboom JCJ, Reitsma PH, Peerlinck KMJ, Briët E. Recessive inheritance of von Willebrand's disease type I. Lancet 1993;341:982-6.
67. Inbal A, Kornbrot N, Mannucci PM, Sadler JE. Very low frequency of "Normandy type" mutations among type 1 von Willebrand disease families. Thromb Haemost 1995;73:324-9.
68. Standen GR, Bignell P, Bowen DJ, Peake IR, Bloom AL. Family studies in von Willebrand's disease by analysis of restriction fragment length polymorphisms and an intragenic variable number tandem repeat (VNTR) sequence. Br J Haematol 1990;76:242-9.
69. Bignell P, Standen GR, Bowen DJ, Peake IR, Bloom AL. Rapid neonatal diagnosis of von Willebrand's disease by use of the polymerase chain reaction. Lancet 1990;336:638-9.
70. Bernardi F, Guerra S, Patracchini P, et al. Von Willebrand disease investigated by two novel RFLPs. Br J Haematol 1988;68:243-8.
71. Inbal A, Kornbrot N, Zivelin A, Shaklai M, Seligsohn U. The inheritance of type I and type III von Willebrand's disease in Israel: linkage analysis, carrier detection and prenatal diagnosis using three intragenic restriction fragment length polymorphisms. Blood Coagul Fibrinolysis 1992;3:167-77.
72. Bray PF. Inherited diseases of platelet glycoproteins: considerations for rapid molecular characterization. Thromb Haemost 1994;72:492-502.
73. Miller JL, Cunningham D, Lyle VA, Finch CN. Mutation in the gene encoding the α chain of platelet glycoprotein Ib in platelet-type von Willebrand disease. Proc Natl Acad Sci USA 1991;88:4761-65.
74. Gralnick HR, Ginsburg D. von Willebrand disease. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, editors. Williams hematology. New York: McGraw-Hill Inc., 1994:1458-80.
75. Miller CH, Graham JB, Goldin LR, Elston RC. Genetics of classic von Willebrand's disease. II. Optimal assignment of the heterozygous genotype (diagnosis) by discriminant analysis. Blood 1979;54:137-45.
76. Thompson SG, Duckert F, Haverkate F, Thomson JM. The measurement of haemostatic factors in 16 European laboratories: quality assessment for the Multicentre ECAT Angina Pectoris Study. Report from the European Concerted Action on Thrombosis and Disabilities (ECAT). Thromb Haemost 1989;61:301-6.
77. Favaloro EJ, Facey D, Grispo L. Laboratory assessment of von Willebrand factor. Use of different assays can influence the diagnosis of von Willebrand's disease, dependent on differing sensitivity to sample preparation and differential recognition of high molecular weight vWf forms. Am J Clin Pathol 1995;104:264-71.
78. Werner E, Werner A, Gies L, Shults J, Adelman R. Variability of von Willebrand factor levels: a chronobiological study [abstract]. Blood 1994;84:192a.
79. Blombäck M, Eneroth P, Andersson O, Anvret M. On laboratory problems in diagnosing mild von Willebrand's disease. Am J Hematol 1992;40:117-20.
80. Abildgaard CF, Suzuki Z, Harrison J, Jefcoat K, Zimmerman TS. Serial studies in von Willebrand's disease: variability versus "variants". Blood 1980;56:712-6.
81. Goldin LR, Elston RC, Graham JB, Miller CH. Genetic analysis of von Willebrand's disease in two large pedigrees: a multivariate approach. Am J Med Genet 1980;7:279-93.
82. Miller CH, Graham JB, Goldin LR, Elston RC. Genetics of classic von Willebrand's disease. I. Phenotypic variation within families. Blood 1979;54:117-45.
83. Orstavik KH, Magnus P, Reisner H, Berg K, Graham JB, Nance W. Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet 1985;37:89-101.
84. Stormorken H, Erikssen J. Plasma antithrombin III and factor VIII antigen in relation to angiographic findings, angina and blood groups in middle-aged men. Thromb Haemost 1977;38:874-8.
85. McCallum CJ, Peake IR, Newcombe RG, Bloom AL. Factor VIII levels and blood group antigens [letter]. Thromb Haemost 1983;50:757.
86. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987;69:1691-5.
87. Shima M, Fujimura Y, Nishiyama T, et al. ABO blood group genotype and plasma von Willebrand factor in normal individuals. Vox Sang 1995;68:236-40.
88. 2-macroglobulin and von Willebrand factor possess covalently linked ABO(H) blood group antigens in subjects with corresponding ABO phenotype. Blood 1993;82:663-8.
89. Orstavik KH, Kornstad L, Reisner H, Berg K. Possible effect of secretor locus on plasma concentration of factor VIII and von Willebrand factor. Blood 1989;73:990-3.
90. Federici AB, Elder JH, De Marco L, Ruggeri ZM, Zimmerman TS. Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation. J Clin Invest 1984;74:2049-55.
91. Conlan MG, Folsom AR, Finch A, et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) study. Thromb Haemost 1993;70:380-5.
92. Sarji KE, Graves JM, Colwell JA. Von Willebrand factor activity in normal subjects: sex difference and variability. Thromb Res 1975;7:885-95.
93. Ratnoff OD, Bennett B. Clues to the pathogenesis of bleeding in von Willebrand's disease. N Engl J Med 1973;289: 1182-3.
94. Ruggeri ZM, Mannucci PM, Lombardi R, Federici AB, Zimmerman TS. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes. Blood 1982;59:1272-8.
95. Bowie EJW, Owen CA Jr, Giles AR. Animal models for the study of factor VIII and von Willebrand factor. In: Zimmerman TS, Ruggeri ZM, editors. Coagulation and bleeding disorders. New York: Marcel Dekker Inc., 1989:305-24.
96. Brooks M, Leith GS, Allen AK, Woods PR, Benson RE, Dodds WJ. Bleeding disorder (von Willebrand disease) in a quarter horse. J Am Vet Med Assoc 1991;198:114-6.
97. ullivan PS, Grubbs ST, Olchowy TWJ, et al. Bleeding diathesis associated with variant von Willebrand factor in a Simmental calf. J Am Vet Med Assoc 1994;205:1763-6.
98. Hogan AG, Muhrer ME, Bogart R. A hemophilia-like disease in swine. Proc Soc Exp Biol Med 1941;48:217-9.
99. Fass DN, Bowie EJW, Owen CA, Zollman PE. Inheritance of porcine von Willebrand's disease: study of a kindred of over 700 pigs. Blood 1979;53:712-9.
100. Bahou WF, Bowie EJW, Fass DN, Ginsburg D. Molecular genetic analysis of porcine von Willebrand disease: tight linkage to the von Willebrand factor locus. Blood 1988;72: 308-13.
101. Bowie EJW, Solberg LA Jr, Fass DN, et al. Transplantation of normal bone marrow into a pig with severe von Willebrand's disease. J Clin Invest 1986;78:26-30.
102. Nichols TC, Samama CM, Bellinger DA, et al. Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras. Proc Natl Acad Sci USA 1995;92:2455-9.
103. Sweeney JD, Novak EK, Reddington M, Takeuchi KH, Swank RT. The RIIIS/J inbred mouse strain as a model for von Willebrand disease. Blood 1990;76:2258-65.
104. Nichols WC, Cooney KA, Mohlke KL, et al. von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene. Blood 1994; 83:3225-31.
105. Mohlke KL, Nichols WC, Westrick RJ, et al. A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11. Proc Natl Acad Sci USA 1996;93:15352-7.
106. Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995;345:152-5.
107. Kernoff LM, Rose AG, Hughes J, Jacobs P. Autopsy findings in an elderly man suffering from severe von Willebrand's disease. Thromb Haemost 1981;46:714-6.
108. Fuster V, Fass DN, Kaye MP, Josa M, Zinsmeister AR, Bowie EJW. Arteriosclerosis in normal and von Willebrand pigs. Circ Res 1982;51:587-93.
109. Badimon L, Steele P, Badimon JJ, Bowie EJ, Fuster V. Aortic atherosclerosis in pigs with heterozygous von Willebrand disease. Comparison with homozygous von Willebrand and normal pigs. Arteriosclerosis 1985;5:366-70.
110. Nichols TC, Bellinger DA, Tate DA, et al. von Willebrand factor and occlusive arterial thrombosis. A study in normal and von Willebrand's disease pigs with diet-induced hypercholesterolemia and atherosclerosis. Arteriosclerosis 1990;10:449-61.